{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T08:55:58Z","timestamp":1791536158636,"version":"4.3.4"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100030969","name":"Sociedad Madrile\u00f1a de Neumolog\u00eda y Cirug\u00eda Tor\u00e1cica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030969","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007509","name":"Sociedad Espa\u00f1ola de Neumolog\u00eda y Cirug\u00eda Tor\u00e1cica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007509","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de Bronconeumolog\u00eda"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.arbres.2026.06.004","type":"journal-article","created":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T18:04:49Z","timestamp":1781460289000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Spanish Clinical Practice Guidelines for the Diagnosis and Management of Alpha-1 Antitrypsin Deficiency: 2026 Update"],"prefix":"10.1016","author":[{"given":"Myriam","family":"Calle Rubio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"L\u00f3pez-Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Casas Maldonado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Torres Dur\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rigau Comas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Barrecheguren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Bustamante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jes\u00fas","family":"Cabero P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Cadenas Men\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Javier","family":"Callejas Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Castillo Corull\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Curi Ch\u00e9rcoles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Jos\u00e9","family":"Das\u00ed Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Layla","family":"Diab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Cruz","family":"Gonz\u00e1lez Villaescusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Goyanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Hern\u00e1ndez P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes","family":"L\u00e1zaro Asegurado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Mart\u00ednez Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Mart\u00ednez Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Javier","family":"Michel de la Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Moya \u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Pastor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Parra Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Pe\u00f1alver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Pons Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Priegue Carrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Rodr\u00edguez Fr\u00edas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlota","family":"Rodr\u00edguez Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Rosario","family":"Ruiz-Serrano de la Espada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Miravitlles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arbres.2026.06.004_bib0380","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1157\/13095974","article-title":"Comit\u00e9 del registro nacional de pacientes con d\u00e9ficit de alfa-1-antitripsina normativa SEPAR: diagn\u00f3stico y tratamiento del d\u00e9ficit de alfa-1-antitripsina","volume":"42","author":"Vidal","year":"2006","journal-title":"Arch Bronconeumol"},{"issue":"4","key":"10.1016\/j.arbres.2026.06.004_bib0385","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.arbres.2014.05.008","article-title":"Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic obstructive pulmonary disease: an update","volume":"51","author":"Casas","year":"2015","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2026.06.004_bib0390","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.arbres.2012.12.001","article-title":"Quality and strength: the GRADE system for formulating recommendations in clinical practice guidelines","volume":"49","author":"Alonso-Coello","year":"2013","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2026.06.004_bib0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinepi.2024.111494","article-title":"GRADE guidance 39: using GRADE-ADOLOPMENT to adopt, adapt or create contextualized recommendations from source guidelines and evidence syntheses","volume":"174","author":"Klugar","year":"2024","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"10.1016\/j.arbres.2026.06.004_bib0400","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.chest.2024.08.037","article-title":"Alpha-1-antitrypsin deficiency targeted testing and augmentation therapy: a Canadian Thoracic Society meta-analysis and clinical practice guideline","volume":"167","author":"Hernandez","year":"2025","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2026.06.004_bib0405","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00610-2017","article-title":"European Respiratory Society statement: diagnosis and treatment of pulmonary disease in \u03b11-antitrypsin deficiency","volume":"50","author":"Miravitlles","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2026.06.004_bib0410","first-page":"132","article-title":"The electrophoretic alpha1-globulin pattern of serum in alpha1-antitrypsin deficiency","volume":"15","author":"Laurell","year":"1963","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.arbres.2026.06.004_bib0415","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2147\/TACG.S257511","article-title":"Known mutations at the cause of alpha-1 antitrypsin deficiency: an updated overview of SERPINA1 variation spectrum","volume":"14","author":"Seixas","year":"2021","journal-title":"Appl Clin Genet"},{"issue":"8","key":"10.1016\/j.arbres.2026.06.004_bib0420","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1373\/clinchem.2007.102798","article-title":"SAPALDIA Team SERPINA1 gene variants in individuals from the general population with reduced alpha1-antitrypsin concentrations","volume":"54","author":"Zorzetto","year":"2008","journal-title":"Clin Chem"},{"issue":"6379","key":"10.1016\/j.arbres.2026.06.004_bib0425","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/357605a0","article-title":"The mechanism of Z \u03b11-antitrypsin accumulation in the liver","volume":"357","author":"Lomas","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.arbres.2026.06.004_bib0430","first-page":"397","volume":"75","year":"1997","journal-title":"Bull World Health Organ"},{"issue":"12","key":"10.1016\/j.arbres.2026.06.004_bib0435","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.arbres.2025.10.008","article-title":"Update 2025 of the Spanish COPD Guidelines (GesEPOC): pharmacological treatment of stable COPD","volume":"61","author":"Miravitlles","year":"2025","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2026.06.004_bib0440","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1164\/rccm.168.7.818","volume":"168","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.arbres.2026.06.004_bib0445","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s13023-023-02830-2","article-title":"The prevalence of bronchiectasis in patients with alpha-1 antitrypsin deficiency: initial report of EARCO","volume":"18","author":"Stockley","year":"2023","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10.1016\/j.arbres.2026.06.004_bib0450","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1378\/chest.117.2.415","article-title":"Distribution of alpha1-antitrypsin alleles in patients with bronchiectasis","volume":"117","author":"Cuvelier","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2026.06.004_bib0455","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.2147\/COPD.S271810","article-title":"The distribution of alpha-1 antitrypsin genotypes between patients with COPD\/emphysema, asthma, and bronchiectasis","volume":"15","author":"Veith","year":"2020","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"6","key":"10.1016\/j.arbres.2026.06.004_bib0460","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.arbres.2023.01.004","article-title":"Alpha1-antitrypsin inherited variants in patients with bronchiectasis","volume":"59","author":"Aliberti","year":"2023","journal-title":"Arch Bronconeumol"},{"issue":"3","key":"10.1016\/j.arbres.2026.06.004_bib0465","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00629-2017","article-title":"European Respiratory Society guidelines for the management of adult bronchiectasis","volume":"50","author":"Polverino","year":"2017","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.arbres.2026.06.004_bib0470","first-page":"222","article-title":"Recommendations for aetiological diagnosis of bronchiectasis","volume":"22","year":"2016","journal-title":"Rev Port Pneumol (2006)"},{"key":"10.1016\/j.arbres.2026.06.004_bib0475","doi-asserted-by":"crossref","unstructured":"Karado\u011fan D, Torres-Duran M, Tanash H, Rodr\u00edguez-Garc\u00eda C, Jensen JS, Corsico AG, et al. EARCO study group. Clinical characteristics of AATD-related COPD patients vary with age at diagnosis: data from the EARCO international registry. BMC Pulm Med. 2025;25(1):321. doi: 10.1186\/s12890-025-03782-y","DOI":"10.1186\/s12890-025-03782-y"},{"issue":"6","key":"10.1016\/j.arbres.2026.06.004_bib0480","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3390\/biom15060807","article-title":"Alpha-1 antitrypsin deficiency and bronchial asthma: current challenges","volume":"15","author":"Lopez-Campos","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.arbres.2026.06.004_bib0485","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-1-4939-7163-3_3","article-title":"Measuring and interpreting serum AAT concentration","volume":"1639","author":"Donato","year":"2017","journal-title":"Methods Mol Biol"},{"issue":"6","key":"10.1016\/j.arbres.2026.06.004_bib0490","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199902113400607","article-title":"Acute-phase proteins and other systemic responses to inflammation","volume":"340","author":"Gabay","year":"1999","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.arbres.2026.06.004_bib0495","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0028-2243(93)90192-F","article-title":"Changes in blood levels of proteinase inhibitors, pregnancy zone protein, steroid carriers, and complement factors induced by oral contraceptives","volume":"51","author":"Nielsen","year":"1993","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"10.1016\/j.arbres.2026.06.004_bib0500","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1080\/15412555.2017.1401600","article-title":"The effects of inflammation on alpha 1 antitrypsin levels in a national screening cohort","volume":"15","author":"Sanders","year":"2018","journal-title":"COPD"},{"issue":"15","key":"10.1016\/j.arbres.2026.06.004_bib0505","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1056\/NEJMra1910234","article-title":"Alpha1-antitrypsin deficiency","volume":"382","author":"Strnad","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arbres.2026.06.004_bib0510","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1183\/09031936.00069709","article-title":"Laboratory testing of individuals with severe alpha1-antitrypsin deficiency in 3 European centres","volume":"35","author":"Miravitlles","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2026.06.004_bib0515","series-title":"Procedimientos t\u00e9cnicos de laboratorios para el diagn\u00f3stico del d\u00e9ficit de alfa-1 antitripsina","first-page":"13","article-title":"Determinaci\u00f3n de la concentraci\u00f3n s\u00e9rica de alfa-1 antitripsina","author":"Belmonte Mula","year":"2022"},{"key":"10.1016\/j.arbres.2026.06.004_bib0520","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.2147\/COPD.S224221","article-title":"Diagnosing alpha-1-antitrypsin deficiency using a PCR\/luminescence-based technology","volume":"14","author":"Veith","year":"2019","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"1","key":"10.1016\/j.arbres.2026.06.004_bib0525","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.arbr.2020.04.010","article-title":"Results of a diagnostic procedure based on multiplex technology on dried blood spots and buccal swabs for subjects with suspected alpha1 antitrypsin deficiency","volume":"57","author":"Lopez-Campos","year":"2021","journal-title":"Arch Bronconeumol (Engl Ed)"},{"key":"10.1016\/j.arbres.2026.06.004_bib0530","article-title":"Laboratory diagnosis by genotyping","volume":"vol. 1639","author":"Belmonte","year":"2017"},{"key":"10.1016\/j.arbres.2026.06.004_bib0535","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2024.148540","article-title":"Real-time PCR detection of PIS and PIZ alleles of SERPINA1 gene using SYBR Green","volume":"921","author":"Ramos-D\u00edaz","year":"2024","journal-title":"Gene"},{"issue":"Suppl. 2","key":"10.1016\/j.arbres.2026.06.004_bib0540","article-title":"Trends in next-generation sequencing and a new era for whole-genome sequencing","volume":"20","author":"Park","year":"2016","journal-title":"Int Neurourol J"},{"issue":"11","key":"10.1016\/j.arbres.2026.06.004_bib0545","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jmoldx.2024.08.002","article-title":"Haplotype-aware detection of SERPINA1 variants by nanopore sequencing","volume":"26","author":"Gonz\u00e1lez-Carracedo","year":"2024","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.arbres.2026.06.004_bib0550","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1172\/JCI110360","article-title":"Replacement therapy of alpha 1-antitrypsin deficiency: reversal of protease-antiprotease imbalance within the alveolar structures of PiZ subjects","volume":"68","author":"Gadek","year":"1981","journal-title":"J Clin Invest"},{"key":"10.1016\/j.arbres.2026.06.004_bib0555","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1164\/ajrccm.160.5.9901055","article-title":"A randomized clinical trial of alpha-1-antitrypsin augmentation therapy","volume":"160","author":"Dirksen","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.arbres.2026.06.004_bib0560","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1183\/09031936.00159408","article-title":"Exploring the role of CT densitometry: a randomized study of augmentation therapy in alpha1-antitrypsin deficiency","volume":"33","author":"Dirksen","year":"2009","journal-title":"Eur Respir J"},{"issue":"9991","key":"10.1016\/j.arbres.2026.06.004_bib0565","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0140-6736(15)60860-1","article-title":"Intravenous augmentation treatment and lung density in severe alpha1 antitrypsin deficiency (RAPID): a randomized, double-blind, placebo-controlled trial","volume":"386","author":"Chapman","year":"2015","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.arbres.2026.06.004_bib0570","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3390\/biom15040599","article-title":"Progression and augmentation therapy in PiSZ and PiZZ alpha-1 antitrypsin deficiency: a longitudinal functional and densitometric study","volume":"15","author":"Esmaili","year":"2025","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.arbres.2026.06.004_bib0575","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1164\/ajrccm.158.1.9712017","article-title":"Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin","volume":"158","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2026.06.004_bib0580","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.2147\/COPD.S263725","article-title":"Alpha-1 antitrypsin augmentation therapy improves survival in severely deficient patients with predicted FEV1 between 10% and 60%: a retrospective analysis of the NHLBI Alpha-1 Antitrypsin Deficiency Registry","volume":"15","author":"Rahaghi","year":"2020","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.arbres.2026.06.004_bib0585","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2147\/COPD.S8577","article-title":"Alpha-1-antitrypsin augmentation therapy in deficient individuals enrolled in the Alpha-1 Foundation DNA and Tissue Bank","volume":"4","author":"Tonelli","year":"2009","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"10","key":"10.1016\/j.arbres.2026.06.004_bib0590","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1183\/09031936.97.10102260","article-title":"Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency?","volume":"10","author":"Seersholm","year":"1997","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.arbres.2026.06.004_bib0595","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1183\/09031936.98.11020428","article-title":"Long-term treatment of alpha1-antitrypsin deficiency-related pulmonary emphysema with human alpha1-antitrypsin","volume":"11","author":"Wencker","year":"1998","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2026.06.004_bib0600","article-title":"The Alpha-1 International Registry (AIR): a European database for longitudinal evaluation of patients with severe alpha-1 antitrypsin deficiency","volume":"181","author":"Schouten","year":"2021","journal-title":"Respir Med"},{"issue":"9","key":"10.1016\/j.arbres.2026.06.004_bib0605","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1164\/rccm.202305-0863OC","article-title":"Augmentation therapy for severe alpha-1 antitrypsin deficiency improves survival and is decoupled from spirometric decline: a multinational registry analysis","volume":"208","author":"Fraughen","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.arbres.2026.06.004_bib0610","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-2600(16)30430-1","article-title":"Long-term efficacy and safety of alpha1 proteinase inhibitor treatment for emphysema caused by severe alpha1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE)","volume":"5","author":"McElvaney","year":"2017","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.arbres.2026.06.004_bib0615","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/1753465812438387","article-title":"Reduction of severe exacerbations and hospitalization-derived costs in alpha-1-antitrypsin-deficient patients treated with alpha-1-antitrypsin augmentation therapy","volume":"6","author":"Barros-Tiz\u00f3n","year":"2012","journal-title":"Ther Adv Respir Dis"},{"issue":"3","key":"10.1016\/j.arbres.2026.06.004_bib0620","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1164\/rccm.201901-0010OC","article-title":"The biological effects of double-dose alpha-1 antitrypsin augmentation therapy: a pilot clinical trial","volume":"200","author":"Campos","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.arbres.2026.06.004_bib0625","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1136\/thx.2005.057943","article-title":"Alpha-1-antitrypsin deficiency: optimal therapeutic regimen based on population pharmacokinetics","volume":"61","author":"Soy","year":"2006","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.arbres.2026.06.004_bib0630","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3109\/15412555.2013.800852","article-title":"Safety and pharmacokinetics of 120mg\/kg versus 60mg\/kg weekly intravenous infusions of alpha-1 proteinase inhibitor in alpha-1 antitrypsin deficiency: a multicenter, randomized, double-blind, crossover study (SPARK)","volume":"10","author":"Campos","year":"2013","journal-title":"COPD"},{"issue":"4","key":"10.1016\/j.arbres.2026.06.004_bib0635","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s12325-018-0690-4","article-title":"Impact of a health management program on health care outcomes among patients receiving augmentation therapy for alpha 1-antitrypsin deficiency: an insurance claims analysis","volume":"35","author":"Campos","year":"2018","journal-title":"Adv Ther"},{"key":"10.1016\/j.arbres.2026.06.004_bib0640","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.2147\/COPD.S410611","article-title":"Recommendations for the implementation of the self-administration of alpha-1 antitrypsin","volume":"18","author":"Torres-Dur\u00e1n","year":"2023","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"8","key":"10.1016\/j.arbres.2026.06.004_bib0645","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1136\/thoraxjnl-2011-201321","article-title":"Serum levels and genotype distribution of \u03b11-antitrypsin in the general population","volume":"67","author":"Ferrarotti","year":"2012","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.arbres.2026.06.004_bib0755","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1378\/chest.100.3.703","article-title":"Use of a highly purified alpha 1-antitrypsin standard to establish ranges for the common normal and deficient alpha 1-antitrypsin phenotypes","volume":"100","author":"Brantly","year":"1991","journal-title":"Chest."},{"issue":"1","key":"10.1016\/j.arbres.2026.06.004_bib0760","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12931-015-0256-9","article-title":"Quantitation of circulating wild-type alpha-1-antitrypsin in heterozygous carriers of the S and Z deficiency alleles","volume":"16","author":"Donato","year":"2015","journal-title":"Respir Res."},{"issue":"3","key":"10.1016\/j.arbres.2026.06.004_bib0765","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1136\/thoraxjnl-2020-215250","article-title":"SZ alpha-1 antitrypsin deficiency and pulmonary disease: more like MZ, not like ZZ","volume":"76","author":"Franciosi","year":"2021","journal-title":"Thorax."},{"issue":"1","key":"10.1016\/j.arbres.2026.06.004_bib0770","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1164\/rccm.202002-0262OC","article-title":"Clarifying the Risk of Lung Disease in SZ Alpha-1 Antitrypsin Deficiency","volume":"202","author":"Franciosi","year":"2020","journal-title":"Am J Respir Crit Care Med."},{"issue":"4","key":"10.1016\/j.arbres.2026.06.004_bib0650","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1080\/15412555.2020.1795824","article-title":"The importance of reference centers and registries for rare diseases: the example of alpha-1 antitrypsin deficiency","volume":"17","author":"Miravitlles","year":"2020","journal-title":"COPD"},{"issue":"1","key":"10.1016\/j.arbres.2026.06.004_bib0655","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12931-023-02338-0","article-title":"The impact of diagnostic delay on survival in alpha-1-antitrypsin deficiency: results from the Austrian Alpha-1 Lung Registry","volume":"24","author":"Meischl","year":"2023","journal-title":"Respir Res"},{"key":"10.1016\/j.arbres.2026.06.004_bib0660","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00055-2019","article-title":"The withdrawal of replacement therapy and outcomes in alpha-1 antitrypsin deficiency lung transplant recipients","volume":"53","author":"Kleinerova","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2026.06.004_bib0665","article-title":"Lung transplant outcomes for recipients with alpha-1 antitrypsin deficiency, by use of alpha-1 antitrypsin augmentation therapy","volume":"7","author":"Oak","year":"2024","journal-title":"JHLT Open"},{"key":"10.1016\/j.arbres.2026.06.004_bib0670","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJMc1915484","article-title":"Consequences of abrupt cessation of alpha-1 antitrypsin replacement therapy","volume":"382","author":"McElvaney","year":"2020","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.arbres.2026.06.004_bib0675","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.healun.2016.03.006","article-title":"Human \u03b11-antitrypsin improves early posttransplant lung function: preclinical studies in a pig lung transplant model","volume":"35","author":"Iskender","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.arbres.2026.06.004_bib0680","doi-asserted-by":"crossref","first-page":"153","DOI":"10.21926\/obm.transplant.2104153","article-title":"Experience with alpha-1 proteinase replacement after lung transplantation in alpha-1 antitrypsin deficiency: a single-center case series","volume":"5","author":"Afshar","year":"2021","journal-title":"OBM Transplant"},{"key":"10.1016\/j.arbres.2026.06.004_bib0685","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s12931-021-01890-x","article-title":"Alpha-1 antitrypsin attenuates acute rejection of orthotopic murine lung allografts","volume":"22","author":"Nakagiri","year":"2021","journal-title":"Respir Res"},{"issue":"1","key":"10.1016\/j.arbres.2026.06.004_bib0690","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0301-2115(01)00356-6","article-title":"Serum alpha-1-antitrypsin concentration during normal and diabetic pregnancy","volume":"99","author":"Lisowska-Myjak","year":"2001","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.arbres.2026.06.004_bib0695","article-title":"Alpha-1 antitrypsin deficiency and augmentation therapy in pregnancy: 2 case reports","volume":"11","author":"Annunziata","year":"2024","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"10.1016\/j.arbres.2026.06.004_bib0700","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1080\/15412555.2020.1754778","article-title":"Alpha-1 antitrypsin deficiency and pregnancy","volume":"17","author":"Gaeckle","year":"2020","journal-title":"COPD"},{"issue":"2","key":"10.1016\/j.arbres.2026.06.004_bib0705","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2023.08.038","article-title":"Alpha-1 antitrypsin augmentation and the liver phenotype of adults with alpha-1 antitrypsin deficiency (genotype Pi*ZZ)","volume":"22","author":"Fromme","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.arbres.2026.06.004_bib0710","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/bjd.14309","article-title":"Neutrophilic panniculitis associated with alpha-1-antitrypsin deficiency: an update","volume":"174","author":"Blanco","year":"2016","journal-title":"Br J Dermatol"},{"issue":"178","key":"10.1016\/j.arbres.2026.06.004_bib0715","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0088-2025","article-title":"Alpha-1 antitrypsin deficiency and granulomatosis with polyangiitis: a systematic review and meta-analysis","volume":"34","author":"Alluhibi","year":"2025","journal-title":"Eur Respir Rev"},{"issue":"4","key":"10.1016\/j.arbres.2026.06.004_bib0720","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jaad.2021.01.074","article-title":"Alpha-1 antitrypsin deficiency-associated panniculitis","volume":"87","author":"Franciosi","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.arbres.2026.06.004_bib0725","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1750-1172-6-14","article-title":"Efficacy of alpha1-antitrypsin augmentation therapy in conditions other than pulmonary emphysema","volume":"6","author":"Blanco","year":"2011","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"10.1016\/j.arbres.2026.06.004_bib0730","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13023-023-02635-3","article-title":"Strategic discussion on funding and access to therapies targeting rare diseases in Spain: an expert consensus paper","volume":"18","author":"Zozaya","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.arbres.2026.06.004_bib0735","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.953827","article-title":"Regional well-being inequalities arising from health care expenditure public policies in Spain","volume":"10","author":"Valls Mart\u00ednez","year":"2022","journal-title":"Front Public Health"},{"key":"10.1016\/j.arbres.2026.06.004_bib0740","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2147\/COPD.S234646","article-title":"New patient-centric approaches to the management of alpha-1 antitrypsin deficiency","volume":"15","author":"Chorostowska-Wynimko","year":"2020","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.arbres.2026.06.004_bib0745","doi-asserted-by":"crossref","DOI":"10.1002\/ueg2.70009","article-title":"Diagnosis and monitoring pathways using noninvasive tests in patients with alpha-1 antitrypsin deficiency-associated liver disease: results from an expert Delphi panel","author":"Clark","year":"2025","journal-title":"United European Gastroenterol J"},{"issue":"1","key":"10.1016\/j.arbres.2026.06.004_bib0750","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/s12931-024-02929-5","article-title":"Assessment and monitoring of lung disease in patients with severe alpha 1 antitrypsin deficiency: a European Delphi consensus of the EARCO group","volume":"25","author":"Miravitlles","year":"2024","journal-title":"Respir Res"}],"container-title":["Archivos de Bronconeumolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030028962600219X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030028962600219X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T19:39:03Z","timestamp":1783712343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030028962600219X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":79,"alternative-id":["S030028962600219X"],"URL":"https:\/\/doi.org\/10.1016\/j.arbres.2026.06.004","relation":{},"ISSN":["0300-2896"],"issn-type":[{"value":"0300-2896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spanish Clinical Practice Guidelines for the Diagnosis and Management of Alpha-1 Antitrypsin Deficiency: 2026 Update","name":"articletitle","label":"Article Title"},{"value":"Archivos de Bronconeumolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arbres.2026.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 SEPAR. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}